Lv2
132 积分 2024-03-18 加入
A pivotal phase 2 single-arm study of glecirasib (JAB-21822) in patients with NSCLC harboring KRAS G12C mutation
1个月前
已完结
Phase 1b/2 study of penpulimab (AK105), an antiprogrammed cell death‐1 immunoglobulin G1 antibody, in advanced or metastatic solid tumors (AK105‐204)
1个月前
已完结
The role and molecular mechanism of NOP16 in the pathogenesis of nasopharyngeal carcinoma
1个月前
已完结
Ubiquitin-specific peptidase 49 promotes adenocarcinoma of the esophagogastric junction malignant progression via activating SHCBP1–β-catenin–GPX4 axis
1个月前
已完结
TMEM160 promotes tumor immune evasion and radiotherapy resistance via PD-L1 binding in colorectal cancer
2个月前
已完结
Association Between Duration of Immunotherapy and Overall Survival in Advanced Non–Small Cell Lung Cancer
3个月前
已完结
High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment
3个月前
已完结
High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment
3个月前
已关闭
Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapy
3个月前
已完结
Molecular Characterization of Acquired Resistance to KRASG12C-EGFR Inhibition in Colorectal Cancer
3个月前
已完结
皖公网安备34019202002308
